Answers are grounded in this paper and cite their sources.
Combination antiretroviral therapy has transformed HIV-1 infection into a chronic, manageable condition, yet lifelong treatment remains necessary due to the persistence of latent reservoirs and the continual emergence of drug-resistant variants. Most approved antivirals target early entry or enzymatic steps, leaving the late phase of replication—Gag trafficking, lattice assembly, membrane scission, envelope incorporation, and protease-driven maturation—underexplored as a target for antiviral inhibitors. Recent advances in cryo-electron microscopy, cryo-electron tomography, single-molecule and live-cell imaging, and integrative systems-level approaches reveal that HIV-1 assembly and egress are not linear, virus-autonomous reactions. Instead, they are spatially and temporally coordinated processes embedded within host cellular architecture. Viral RNA scaffolding, plasma membrane composition and curvature, microdomain identity, cytoskeletal dynamics, and endosomal sorting complexes required for transport (ESCRT)-mediated membrane fission are tightly coupled to Gag lattice formation, establishing regulated checkpoints that vary across cell types and tissue microenvironments. This host-integrated framework reframes HIV-1 morphogenesis as a systems-level process and highlights structurally constrained, host-dependent nodes as promising targets for next-generation antiviral strategies.
No takes yet. Share an insight, caveat, or question.
Elkady et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: